Deepak Chadha is Former Chief R&D Officer & COO of Brickell Biotech, Inc.. Currently has a direct ownership of 22,314 shares of BBI, which is worth approximately $39,272. The most recent transaction as insider was on Sep 01, 2023, when has been sold 14,978 shares (Common Stock) at a price of $0.62 per share, resulting in proceeds of $9,286. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.3K
0% 3M change
0% 12M change
Total Value Held $39,272

Deepak Chadha Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 01 2023
SELL
Payment of exercise price or tax liability
$9,286 $0.62 p/Share
14,978 Reduced 40.16%
22,314 Common Stock
Sep 01 2023
BUY
Exercise of conversion of derivative security
-
35,000 Added 48.41%
37,292 Common Stock
May 19 2021
BUY
Open market or private purchase
$10,375 $0.83 p/Share
12,500 Added 13.79%
78,167 Common Stock
May 18 2021
BUY
Open market or private purchase
$2,214 $0.82 p/Share
2,700 Added 3.95%
65,667 Common Stock
Mar 16 2021
SELL
Payment of exercise price or tax liability
$9,975 $1.14 p/Share
8,750 Reduced 12.2%
62,967 Common Stock
Mar 16 2021
BUY
Exercise of conversion of derivative security
-
25,000 Added 25.85%
71,717 Common Stock
DC

Deepak Chadha

Former Chief R&D Officer & COO
Boulder, CO

Track Institutional and Insider Activities on BBI

Follow Brickell Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBI shares.

Notify only if

Insider Trading

Get notified when an Brickell Biotech, Inc. insider buys or sells BBI shares.

Notify only if

News

Receive news related to Brickell Biotech, Inc.

Track Activities on BBI